Financials
- Market Capitalization 2.01 B
- Employee 59
- Founded 2019
- CEO N/A
- Website www.sionnatx.com
- Headquarter Delaware, United States
- FIGI BBG016X2DC85
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-21.88
ratio cours/chiffre d'affaires
4 110.11
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 1993 | ABCL AbCellera Biologics Inc. - Common Shares | 6.80 USD | +4.29% | -13.04% | +24.31% | +54.20% | 2.08 B USD | ||
| 1999 | VRDN Viridian Therapeutics, Inc. - Common Stock | 19.14 USD | +0.79% | -7.04% | +15.44% | -14.74% | 1.97 B USD | ||
| 2003 | ANAB AnaptysBio, Inc. - Common Stock | 64.96 USD | -6.95% | -3.69% | +14.69% | +84.55% | 1.89 B USD | ||
| 2007 | SRPT Sarepta Therapeutics, Inc. - Common Stock | 18.14 USD | -3.61% | -7.35% | +15.69% | -7.07% | 1.92 B USD |